<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>My research experience so far on Letícia Lopes</title>
    <link>//localhost:1313/project/</link>
    <description>Recent content in My research experience so far on Letícia Lopes</description>
    <generator>Hugo</generator>
    <language>en</language>
    <copyright>© 2025 Letícia Lopes</copyright>
    <lastBuildDate>Tue, 14 Jan 2025 00:00:00 +0000</lastBuildDate>
    <atom:link href="//localhost:1313/project/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Cancer Research</title>
      <link>//localhost:1313/project/cancer/</link>
      <pubDate>Tue, 14 Jan 2025 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/project/cancer/</guid>
      <description>&lt;h2 id=&#34;summary&#34;&gt;Summary&#xD;&#xA;  &lt;a href=&#34;#summary&#34;&gt;&lt;svg class=&#34;anchor-symbol&#34; aria-hidden=&#34;true&#34; height=&#34;26&#34; width=&#34;26&#34; viewBox=&#34;0 0 22 22&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34;&gt;&#xD;&#xA;      &lt;path d=&#34;M0 0h24v24H0z&#34; fill=&#34;currentColor&#34;&gt;&lt;/path&gt;&#xD;&#xA;      &lt;path d=&#34;M3.9 12c0-1.71 1.39-3.1 3.1-3.1h4V7H7c-2.76.0-5 2.24-5 5s2.24 5 5 5h4v-1.9H7c-1.71.0-3.1-1.39-3.1-3.1zM8 13h8v-2H8v2zm9-6h-4v1.9h4c1.71.0 3.1 1.39 3.1 3.1s-1.39 3.1-3.1 3.1h-4V17h4c2.76.0 5-2.24 5-5s-2.24-5-5-5z&#34;&gt;&lt;/path&gt;&#xD;&#xA;    &lt;/svg&gt;&lt;/a&gt;&#xD;&#xA;&lt;/h2&gt;&#xD;&#xA;&lt;p&gt;This project brings together different aspects of cancer research, from systemic effects such as cancer-associated cachexia to the tumor–immune interface in immunotherapy in cancer. Using transcriptomic analysis, digital pathology, and immune profiling, we aim to better understand how inflammation, microRNAs, and immune evasion contribute to cancer progression.&#xA;The research spans both public data integration (e.g. TCGA, GEO) and in-house experimental pipelines combining RNA-seq and image-based tissue analysis. These complementary approaches provide insights into the molecular and immune landscapes of cancer.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Autoantibodies and Symptom Accumulation in COVID-19</title>
      <link>//localhost:1313/project/covid/</link>
      <pubDate>Mon, 13 Jan 2025 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/project/covid/</guid>
      <description>&lt;h2 id=&#34;summary&#34;&gt;Summary&#xD;&#xA;  &lt;a href=&#34;#summary&#34;&gt;&lt;svg class=&#34;anchor-symbol&#34; aria-hidden=&#34;true&#34; height=&#34;26&#34; width=&#34;26&#34; viewBox=&#34;0 0 22 22&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34;&gt;&#xD;&#xA;      &lt;path d=&#34;M0 0h24v24H0z&#34; fill=&#34;currentColor&#34;&gt;&lt;/path&gt;&#xD;&#xA;      &lt;path d=&#34;M3.9 12c0-1.71 1.39-3.1 3.1-3.1h4V7H7c-2.76.0-5 2.24-5 5s2.24 5 5 5h4v-1.9H7c-1.71.0-3.1-1.39-3.1-3.1zM8 13h8v-2H8v2zm9-6h-4v1.9h4c1.71.0 3.1 1.39 3.1 3.1s-1.39 3.1-3.1 3.1h-4V17h4c2.76.0 5-2.24 5-5s-2.24-5-5-5z&#34;&gt;&lt;/path&gt;&#xD;&#xA;    &lt;/svg&gt;&lt;/a&gt;&#xD;&#xA;&lt;/h2&gt;&#xD;&#xA;&lt;p&gt;This project investigates the role of anti-AGTR1 autoantibodies in the progression and accumulation of COVID-19 symptoms. We combined multi-omics, clinical data, and network-based approaches to understand how persistent immune dysregulation may contribute to long COVID phenotypes.&#xA;The analysis revealed that elevated anti-AGTR1 levels were associated with an increased number of reported symptoms across individuals. These findings suggest a potential autoimmune component to COVID-19 symptom persistence and highlight new biomarkers for future investigation.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Muscle microRNAs and Atrophy</title>
      <link>//localhost:1313/project/muscle/</link>
      <pubDate>Thu, 01 Feb 2024 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/project/muscle/</guid>
      <description>&lt;h2 id=&#34;summary&#34;&gt;Summary&#xD;&#xA;  &lt;a href=&#34;#summary&#34;&gt;&lt;svg class=&#34;anchor-symbol&#34; aria-hidden=&#34;true&#34; height=&#34;26&#34; width=&#34;26&#34; viewBox=&#34;0 0 22 22&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34;&gt;&#xD;&#xA;      &lt;path d=&#34;M0 0h24v24H0z&#34; fill=&#34;currentColor&#34;&gt;&lt;/path&gt;&#xD;&#xA;      &lt;path d=&#34;M3.9 12c0-1.71 1.39-3.1 3.1-3.1h4V7H7c-2.76.0-5 2.24-5 5s2.24 5 5 5h4v-1.9H7c-1.71.0-3.1-1.39-3.1-3.1zM8 13h8v-2H8v2zm9-6h-4v1.9h4c1.71.0 3.1 1.39 3.1 3.1s-1.39 3.1-3.1 3.1h-4V17h4c2.76.0 5-2.24 5-5s-2.24-5-5-5z&#34;&gt;&lt;/path&gt;&#xD;&#xA;    &lt;/svg&gt;&lt;/a&gt;&#xD;&#xA;&lt;/h2&gt;&#xD;&#xA;&lt;p&gt;This projects explore the role of microRNAs in muscle atrophy, combining transcriptomic analysis and in vitro validation. We investigated how miR-155-5p and miR-497-5p influence muscle cell differentiation and inflammatory pathways in skeletal muscle disorders.&#xA;The studies were conducted using C2C12 cell lines and data integration from public transcriptomic datasets. Molecular targets were identified through differential expression analysis and validated by qPCR, Western blot, and functional assays.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
